Abstract
Background: The study of the mechanisms of liver regeneration is quite an intriguing field that has been extensively modeled. Through the process of compensatory proliferation of the hepatocytes, the liver mass is restored after loss of up to two-thirds of the entire mass. Cyclic nucleotides are intracellular second messengers which are involved in the transduction of a diverse array of stimuli, mediating metabolic and growth regulation. The relationship between cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) signaling and liver regeneration has somehow been elusive to pioneer researchers in the field of liver regeneration. In this review, we will highlight the mechanistic approach involving cyclic nucleotide signaling and its regulation of cell cycle progression in proliferating hepatocytes, highlighting its usefulness to devising therapeutic tools for managing liver diseases.
Method: A structured search and review of relevant papers was conducted by the authors.
Results: Authors included forty-two peer-reviewed literature in the review which identified possible roles of cyclic nucleotides in hepatocyte proliferation.
Conclusion: This review article confirms the biological importance of cyclic nucleotides and the mediatory growth signaling events that could bring about compensatory proliferation of the liver tissues.
Keywords: Cyclic nucleotides, liver regeneration, compensatory proliferation, cyclic AMP, protein kinase A, GPCR.
Graphical Abstract
Current Drug Metabolism
Title:The Role of Cyclic Nucleotides in Compensatory Hepatocyte Proliferation
Volume: 18 Issue: 12
Author(s): Oladimeji Aladelokun, Jose Manautou*Li Wang*
Affiliation:
- Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, Storrs, CT 06269,United States
- Department of Physiology and Neurobiology, The Institute for Systems Genomics, University of Connecticut, Storrs, CT 06269,United States
Keywords: Cyclic nucleotides, liver regeneration, compensatory proliferation, cyclic AMP, protein kinase A, GPCR.
Abstract: Background: The study of the mechanisms of liver regeneration is quite an intriguing field that has been extensively modeled. Through the process of compensatory proliferation of the hepatocytes, the liver mass is restored after loss of up to two-thirds of the entire mass. Cyclic nucleotides are intracellular second messengers which are involved in the transduction of a diverse array of stimuli, mediating metabolic and growth regulation. The relationship between cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) signaling and liver regeneration has somehow been elusive to pioneer researchers in the field of liver regeneration. In this review, we will highlight the mechanistic approach involving cyclic nucleotide signaling and its regulation of cell cycle progression in proliferating hepatocytes, highlighting its usefulness to devising therapeutic tools for managing liver diseases.
Method: A structured search and review of relevant papers was conducted by the authors.
Results: Authors included forty-two peer-reviewed literature in the review which identified possible roles of cyclic nucleotides in hepatocyte proliferation.
Conclusion: This review article confirms the biological importance of cyclic nucleotides and the mediatory growth signaling events that could bring about compensatory proliferation of the liver tissues.
Export Options
About this article
Cite this article as:
Aladelokun Oladimeji , Manautou Jose*, Wang Li *, The Role of Cyclic Nucleotides in Compensatory Hepatocyte Proliferation, Current Drug Metabolism 2017; 18 (12) . https://dx.doi.org/10.2174/1389200218666171101125520
DOI https://dx.doi.org/10.2174/1389200218666171101125520 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cytokine Profile in Patients Infected with Anisakis simplex in Endemic Areas: Dietary Intervention with Polyphenols: A Working Hypothesis
Endocrine, Metabolic & Immune Disorders - Drug Targets Cellular and Molecular Effects of Macrolides on Leukocyte Function
Current Pharmaceutical Design Unravelling the Role of Infectious Agents in the Pathogenesis of Human Autoimmunity: The Hypothesis of the Retroviral Involvement Revisited
Current Molecular Medicine MicroRNAs in Colorectal Neoplasia: From Pathobiology to Clinical Applications
Current Pharmaceutical Biotechnology Targeting Endothelial Progenitor Cells in Cancer as a Novel Biomarker and Anti-Angiogenic Therapy
Current Stem Cell Research & Therapy Review of Recent Clinical Developments and Patents for the Treatment of Autoimmune and Inflammatory Diseases by Mesenchymal Stromal Cells
Recent Patents on Regenerative Medicine Topical Formulations and Intradermal Injections of Tranexamic Acid in the Treatment of Hyperpigmentation - A Review
Letters in Drug Design & Discovery Meet Our Editorial Board Member
Recent Patents on Inflammation & Allergy Drug Discovery Angiogenesis-Related Cytokines in Rheumatoid Arthritis
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Growth Factors and Bone Formation in Osteoporosis: Roles for Fibroblast Growth Factor and Transforming Growth Factor Beta
Current Pharmaceutical Design Anticancer Actions of Omega-3 Fatty Acids - Current State and Future Perspectives
Anti-Cancer Agents in Medicinal Chemistry Xenobiotic Metabolism in Human Skin and 3D Human Skin Reconstructs: A Review
Current Drug Metabolism Genetic Factors as a Cause of Miscarriage
Current Medicinal Chemistry Compounds that Combine Aldose Reductase Inhibitory Activity and Ability to Prevent the Glycation (Glucation and/or Fructation) of Proteins as Putative Pharmacotherapeutic Agents
Drug Design Reviews - Online (Discontinued) A Novel Highly Selective Cannabinoid CB2 Agonist Reduces in vitro Growth and TGF-beta Release of Human Glial Cell Tumors
Central Nervous System Agents in Medicinal Chemistry Editorial [Hot Topic: Targeting Arterial Thrombosis - Current Concepts and Future Developments (Guest Editor: Florian Krotz)]
Current Drug Targets Sleep Duration as a Risk Factor for Cardiovascular Disease- a Review of the Recent Literature
Current Cardiology Reviews Cytokine Transport Across the Injured Blood-Spinal Cord Barrier
Current Pharmaceutical Design Protein Geranylgeranyltransferase Type 1 as a Target in Cancer
Current Cancer Drug Targets A Systematic Review on the Sinomenine Derivatives
Mini-Reviews in Medicinal Chemistry